People: Dr.Reddy's Laboratories Ltd (REDY.BO)

REDY.BO on Bombay Stock Exchange

2,067.00INR
1:09am EDT
Price Change (% chg)

Rs-10.65 (-0.51%)
Prev Close
Rs1,993.50
Open
Rs2,069.00
Day's High
Rs2,101.85
Day's Low
Rs2,051.20
Volume
7,138
Avg. Vol
17,355
52-wk High
Rs2,150.90
52-wk Low
Rs1,528.00

Search Stocks

Prasad, G. 

Brief Biography

Mr. G. V. Prasad is Executive Chairman of the Board, Chief Executive Officer of Dr. Reddy’s Laboratories Limited. He has been appointed as Executive Chairman of the Board of the Company effective March 30, 2013. He joined the Board in 1986 and leads the core team that drives the growth and performance of Dr. Reddy’s. He has been Vice-Chairman & CEO of Dr. Reddy’s since 2001, when Cheminor Drugs Ltd, the company of which he was then Managing Director, merged with Dr. Reddy’s. Prasad has played a key role in the evolution of Dr. Reddy’s from a mid-sized pharmaceutical company into a globally respected pharmaceutical. He is widely credited as the architect of Dr. Reddy’s global generics strategy. He is dedicated to building the innovation side of the business and drives the Sustainability agenda at Dr. Reddy’s. He holds a degree in Chemical Engineering from the Illinois Institute of Technology, Chicago, USA and a Masters in Industrial Administration from Purdue University, USA.

Basic Compensation

Total Annual Compensation, INR Long-Term Incentive Plans, INR All Other, INR Fiscal Year Total, INR
78,800,000 -- 2,783,000 81,583,000

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Name Fiscal Year Total

G. Prasad

81,583,000

Satish Reddy

79,062,000

Saumen Chakraborty

15,000,000

R. Ananthanarayanan

--

Abhijit Mukherjee

14,600,000

Amit Biswas

--
As Of 30 Mar 2012
Search Stocks